Safety & Efficacy

Ensure patient safety and measure compound effectiveness by driving high-quality data

INCREASE YOUR STATISTICAL POWER WITH QUALITY RESULTS

We specialize in the most widely deployed solutions in centralized electronic clinical outcome assessments (eCOAs), respiratory and cardiac safety. Three integrated solutions are designed to ensure patient safety and measure the effectiveness of your study compound: ERT eCOA, Respiratory and Cardiac Safety solutions.

STREAMLINED
No more struggling with manual, paper-based systems that are prone to error and compromise data quality.

SIMPLE
Easily add countries, languages and import/export requirements to your trials.

IMPACTFUL
Get strategic insight into changing regulatory requirements and guidance.


LET OUR EXPERIENCE MINIMIZE RISK & COMPLEXITY IN YOUR TRIAL

We have over 50 years of combined clinical, therapeutic and regulatory experience as well as technology and process-related insights. Using this experience and these insights, we help you move ahead quickly and with confidence.


9500
total trials managed
550
total drug approvals supported
230k
total sites supported
3M
patients enrolled
106
countries supported
114
languages supported

GOODBYE UNCERTAINTY. HELLO CONFIDENCE.

We leverage decades of experience collecting and analyzing clinical efficacy and safety endpoints, technology leadership and regulatory expertise to minimize risk and data uncertainty so you can move ahead quickly.

eCOA

Accelerate your research with electronic clinical outcome assessment (eCOA) technology that doesn’t get in the way. Our eCOA technology is simple and predictable with an intuitive environment that collects the same data from any mobile device, any study, anywhere.

120K+ eCOA SITES SUPPORTED

RESPIRATORY

Demand data quality and breathe easy in your respiratory trials. Managing risk and generating high quality data is notably difficult in respiratory trials. Complex protocols, lack of training and collection and analysis inconsistencies create uncertainty about a patient’s eligibility to participate in a trial, patient safety and a compound’s efficacy.

80% OF RECENT RESPIRATORY DRUG APPROVALS SUPPORTED

CARDIAC SAFETY

Monitor every heartbeat with precision and ensure safety. Cardiac safety is the number one reason  promising drugs are halted in development or taken off the market. You need a clinical partner with the most experience and expertise to ensure safety and efficacy. We have more experience than anyone else – regardless of the trial phase or type.

6800 CARDIAC SAFETY TRIALS SUPPORTED